5 year incidence of YAG capsulotomy and PCO after cataract surgery with single-piece monofocal intraocular lenses: a real-world evidence study of 20,763 eyes.
Journal
Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
21
01
2019
accepted:
03
09
2019
revised:
07
08
2019
pubmed:
17
10
2019
medline:
22
6
2021
entrez:
17
10
2019
Statut:
ppublish
Résumé
To evaluate the 3- and 5-year incidence of posterior capsule opacification (PCO) and neodymium-doped yttrium aluminium garnet (Nd:YAG) capsulotomy in patients following cataract surgery, comparing results for different single-piece acrylic hydrophilic and hydrophobic monofocal intraocular lens (IOL) models and other patient factors. Electronic medical record data collected from seven United Kingdom (UK) National Health Service (NHS) ophthalmology clinics for routine, age-related (≥65 years) cataract surgeries that implanted single-piece acrylic monofocal IOLs during 2010-2013 were used to calculate 3- and 5-year incidence of Nd:YAG and PCO. IOL models of Alcon Acrysof, AMO Tecnis, Bausch & Lomb (B & L) Akreos, LenStec Softec, and Rayner Flex were analyzed. Pairwise comparisons were conducted between AcrySof IOLs and other IOLs using Bonferroni adjustment for multiplicity. Multivariate analyses were conducted adjusting for known confounders. The incidence of Nd:YAG capsulotomy ranged between 2.4-12.6% at 3 years and 5.8-19.3% at 5 years post-cataract surgery. Similarly, the incidence of PCO ranged between 4.7-18.6% at 3 years and 7.1-22.6% at 5 years. When comparing all of the single-piece IOLs, AcrySof demonstrated the lowest incidence rates for both PCO and Nd:YAG (P < 0.001 for each comparison). From adjusted logistic regression analysis, AcrySof were associated with lower 3- and 5-year odds of Nd:YAG and PCO incidence. Following cataract surgery with single-piece monofocal IOLs different incidence rates of PCO were observed with different IOLs. AcrySof IOLs were associated with significantly lower incidence of PCO requiring Nd:YAG treatment over periods of 3 and 5 years.
Identifiants
pubmed: 31616057
doi: 10.1038/s41433-019-0630-9
pii: 10.1038/s41433-019-0630-9
pmc: PMC7182577
doi:
Substances chimiques
Acrylic Resins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
960-968Références
Boureau C, Lafuma A, Jeanbat V, Smith AF, Berdeaux G. Cost of cataract surgery after implantation of three intraocular lenses. Clin Ophthalmol. 2009;3:277–85.
pubmed: 19668579
pmcid: 2708987
Cullin F, Busch T, Lundstrom M. Economic considerations related to choice of intraocular lens (IOL) and posterior capsule opacification frequency—a comparison of three different IOLs. Acta Ophthalmol. 2014;92:179–83.
doi: 10.1111/aos.12026
Raj SM, Vasavada AR, Johar SR, Vasavada VA, Vasavada VA. Post-operative capsular opacification: a review. Int J Biomed Sci. 2007;3:237–50.
pubmed: 23675049
pmcid: 3614664
American Academy of Ophthalmology. Nd:YAG laser posterior capsulotomy. https://www.aao.org/munnerlyn-laser-surgery-center/ndyag-laser-posterior-capsulotomy-3 . Accessed 04 Nov 2013.
Perez-Vives C. Biomaterial influence on intraocular lens performance: an overview. J Ophthalmol. 2018;2018:2687385.
doi: 10.1155/2018/2687385
Kossack N, Schindler C, Weinhold I, Hickstein L, Lehne M, Walker J, et al. German claims data analysis to assess impact of different intraocular lenses on posterior capsule opacification and related healthcare costs. J Public Health. 2018;26:81–90.
doi: 10.1007/s10389-017-0851-y
NICE. Cataracts in adults: management. Full guideline. United Kingdom: NICE; 2017. https://www.nice.org.uk/guidance/ng77/evidence/full-guideline-pdf-4655997901 .
Ursell PG, Dhariwal M, Majirska K, Ender F, Kalson-Ray S, Venerus A, et al. Three-year incidence of Nd:YAG capsulotomy and posterior capsule opacification and its relationship to monofocal acrylic IOL biomaterial: a UK real world evidence study. Eye. 2018;32:1579–89.
doi: 10.1038/s41433-018-0131-2
Auffarth GU, Brezin A, Caporossi A, Lafuma A, Mendicute J, Berdeaux G. Comparison of Nd:YAG capsulotomy rates following phacoemulsification with implantation of PMMA, silicone, or acrylic intra-ocular lenses in four European countries. Ophthalmic Epidemiol. 2004;11:319–29.
doi: 10.1080/09286580490515116
Vasavada AR, Praveen MR. Posterior capsule opacification after phacoemulsification: annual review. Asia Pac J Ophthalmol. 2014;3:235–40.
doi: 10.1097/APO.0000000000000080
Ernest PH. Posterior capsule opacification and neodymium: YAG capsulotomy rates with AcrySof acrylic and PhacoFlex II silicone intraocular lenses. J Cataract Refract Surg. 2003;29:1546–50.
doi: 10.1016/S0886-3350(02)01974-0
Ursell PG, Spalton DJ, Pande MV, Hollick EJ, Barman S, Boyce J, et al. Relationship between intraocular lens biomaterials and posterior capsule opacification. J Cataract Refract Surg. 1998;24:352–60.
doi: 10.1016/S0886-3350(98)80323-4
Hollick EJ, Spalton DJ, Ursell PG, Pande MV, Barman SA, Boyce JF, et al. The effect of polymethylmethacrylate, silicone, and polyacrylic intraocular lenses on posterior capsular opacification 3 years after cataract surgery. Ophthalmology. 1999;106:49–54.
doi: 10.1016/S0161-6420(99)90047-7
Chang A, Kugelberg M. Posterior capsule opacification 9 years after phacoemulsification with a hydrophobic and a hydrophilic intraocular lens. Eur J Ophthalmol. 2017;27:164–8.
doi: 10.5301/ejo.5000831
de Lusignan S, Crawford L, Munro N. Creating and using real-world evidence to answer questions about clinical effectiveness. J Innov Health Inform. 2015;22:368–73.
doi: 10.14236/jhi.v22i3.177
FDA. Use of real-world evidence to support regulatory decision-making for medical devices. Guidance for Industry and Food and Drug Administration Staff. U.S.: FDA; 2017. https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm513027.pdf .
NICE Decision Support Unit. The use of real world data for the estimation of treatment effects in NICE decision making. Report by the Decision Support Unit; 2016. Sheffield, United Kingdom. http://nicedsu.org.uk/wp-content/uploads/2018/05/RWD-DSU-REPORT-Updated-DECEMBER-2016.pdf .
Day AC, Donachie PH, Sparrow JM, Johnston RL. The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: Report 1; visual outcomes and complications. Eye. 2015;29:552–60.
doi: 10.1038/eye.2015.3
Jackson TL, Donachie PH, Sparrow JM, Johnston RL. United Kingdom National Ophthalmology Database Study of Vitreoretinal Surgery: Report 1; case mix, complications, and cataract. Eye. 2013;27:644–51.
doi: 10.1038/eye.2013.12
OPCS classification of interventions and procedures, version 4.7 volume II. 2014. London: TSO. ISBN 9780113229918
Ong M, Wang L, Karakelle M. Fibronectin adhesive properties of various intraocular lens materials. Investig Ophthalmol Vis Sci. 2013;54:819.
Petrash JM. Aging and age-related diseases of the ocular lens and vitreous body. Investig Ophthalmol Vis Sci. 2013;54:54–9.
doi: 10.1167/iovs.13-12940
Nishi O, Nishi K, Wickstro¨m K. Preventing lens epithelial cell migration using intraocular lenses with sharp rectangular edges. J Cataract Refract Surg. 2000;26:1543–9.
doi: 10.1016/S0886-3350(00)00426-0
Nishi O, Nishi K. Preventing posterior capsule opacification by creating a discontinuous sharp bend in the capsule. J Cataract Refract Surg. 1999;25:521–6.
doi: 10.1016/S0886-3350(99)80049-2
Peng Q, Visessook N, Apple DJ, et al. Surgical prevention of posterior capsule opacification. Part 3: intraocular lens optic barrier effect as a second line of defense. J Cataract Refract Surg. 2000;26:198–213.
doi: 10.1016/S0886-3350(99)00352-1
Hayashi K, Hayashi H. Posterior capsule opacification in the presence of an intraocular lens with a sharp versus rounded optic edge. Ophthalmology. 2005;112:1550–6.
doi: 10.1016/j.ophtha.2005.03.024
Nagamoto T, Eguchi G. Effect of intraocular lens design on migration of lens epithelial cells onto the posterior capsule. J Cataract Refract Surg. 1997;23:866–72.
doi: 10.1016/S0886-3350(97)80245-3
Tetz M, Wildeck A. Evaluating and defining the sharpness of intraocular lenses: part 1: influence of optic design on the growth of the lens epithelial cells in vitro. J Cataract Refract Surg. 2005;31:2172–9.
doi: 10.1016/j.jcrs.2005.01.025
Nanavaty MA, Zukaite I, Salvage J. Edge profile of commercially available square edged intraocular lenses: Part 2. J Cataract Refract Surg. 2019;45:847–53.
doi: 10.1016/j.jcrs.2018.12.004
Nanavaty MA, Spalton DJ, Boyce J, Brain A, Marshall J. Edge profile of commercially available square-edged intraocular lenses. J Cataract Refractive Surg. 2008;34:677–86.
doi: 10.1016/j.jcrs.2007.12.024
Werner L. Glistenings and surface light scattering in intraocular lenses. J Cataract Refractive Surg. 2010;36:1398–420.
doi: 10.1016/j.jcrs.2010.06.003
Espandar L, Sikder S, Moshirfar M. Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision. Clin Ophthalmol. 2011;5:65–70.
pubmed: 21311658
pmcid: 3033005
Rayner Intraocular Lenses Ltd. /Rayner Surgical Inc. C-flex 570C IFU Device description. United Kingdom. https://www.accessdata.fda.gov/cdrh_docs/pdf6/p060011c.pdf